000			04072nam a2200409 i 4500
999			_c396411 _d396411
001			396411
003			ES-MaUEC
005			20230612115316.0
006			a|||| o|||| 00| 0
007			cr nn 008mamaa
008			220906s2022 xxua o |||| 0|eng d
020			_a9781071625736
024	7		_a10.1007/978-1-0716-2573-6 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRM301.3 .G45 _b2022 EB
245	0	0	_aPharmacogenomics in Drug Discovery and Development _cedited by Qing Yan
250			_a3rd edition 2022
264		1	_aNew York, NY _bSpringer International Publising _c2022
300			_a1 recurso en línea (XIV, 616 páginas) _b54 ilustraciones, 47 ilustraciones a color
336			_atexto _btxt _2rdacontent
337			_aelectrónico _bc _2rdamedia
338			_arecurso electrónico _bcr _2rdacarrier
347			_aarchivo de texto _bPDF
490	0		_aMethods in Molecular Biology _x1940-6029 _v2547
505	0		_aTarget Discovery for Drug Development Using Mendelian Randomization -- Human Leukocyte Antigen (HLA) Testing in Pharmacogenomics -- Pharmacogenomics in Targeted Therapy and Supportive Care Therapies for Cancer -- Pharmacogenomics in Cytotoxic Chemotherapy of Cancer -- Management of Side Effects in the Personalized Medicine Era: Chemotherapy-Induced Peripheral Neuropathy -- The Yin-Yang Dynamics in Cancer Pharmacogenomics and Personalized Medicine -- Design of Personalized Neoantigen RNA Vaccines Against Cancer Based on Next Generation Sequencing Data -- COVID-19 Pharmacotherapy: Drug Development, Repurposing of Drugs, and the Role of Pharmacogenomics -- Pharmacogenomics Informs Cardiovascular Pharmacotherapy -- Pharmacogenomic Screening of Patient-Specific hiPSC-Derived Cardiomyocyte Drug Candidates Using High-Throughput Calcium Imaging -- The Yin-Yang Dynamics in Cardiovascular Pharmacogenomics and Personalized Medicine -- GTPgS Assay for Measuring Agonist-Induced Desensitization of Two Human Polymorphic Alpha2B-Adrenoceptor Variants -- Pharmacogenomics of Alzheimer's Disease: Novel Strategies for Drug Utilization and Development -- Pharmacogenetics of Antipsychotic Treatment in Schizophrenia -- The Pharmacogenetic Impact on the Pharmacokinetics of ADHD Medications -- Pharmacogenetics of Addiction Therapy -- Pharmacogenomics of Opioid Treatment for Pain Management -- The Role of Pharmacogenomics in Postoperative Pain Management -- Pharmacogenetics of Drug Therapies in Rheumatoid Arthritis -- Pharmacogenomics in Children -- Genetic Ancestry Inference for Pharmacogenomics.
520			_aThis new edition offers a state-of-the-art and integrative vision of pharmacogenomics by exploring new concepts and practical methodologies focusing on disease treatments, from cancers to cardiovascular and neurodegenerative disorders and more. The collection of these theoretical and experimental approaches facilitates problem-solving by tackling the complexity of personalized drug discovery and development. Written by leading experts in their fields for the highly successful Methods in Molecular Biology series, the book aims to provide across-the-board resources to support the translation of pharmacogenomics into better individualized health care. Authoritative and up-to-date, Pharmacogenomics in Drug Discovery and Development, Third Edition aims to aid researchers in approaching the challenges in pharmacogenomics and personalized medicine with the introduction of these novel ideas and cutting-edge methodologies.
988			_aSpringer_Protocols_2022
650		7	_2embne _9165192 _aFarmacogenómica
650		7	_2embne _9141808 _aQuímica farmacéutica
776	0	8	_iPrinted edition: _z9781071625729
776	0	8	_iPrinted edition: _z9781071625743
776	0	8	_iPrinted edition: _z9781071625750
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-1-0716-2573-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b06/2023 _dz _eb _zSI